JPH0153038B2 - - Google Patents
Info
- Publication number
- JPH0153038B2 JPH0153038B2 JP56138879A JP13887981A JPH0153038B2 JP H0153038 B2 JPH0153038 B2 JP H0153038B2 JP 56138879 A JP56138879 A JP 56138879A JP 13887981 A JP13887981 A JP 13887981A JP H0153038 B2 JPH0153038 B2 JP H0153038B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- sam
- monophosphoric acid
- producing
- monophosphoric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
本発明は醗酵法によるS−アデノシルメチオニ
ン(以下、SAMと略称する)の製造方法に関し、
更に詳しくは、特定な化合物を添加したメチオニ
ン含有液体培地中で酵母を培養し、SAMを効率
的に製造する方法に関する。
SAMは生体内において脂肪、蛋白質、糖類な
どの代謝に関与する重要な物質である。而して近
時かかるSAMに肝血症、過度脂血症、動脈硬化
症、抑うつ病および神経病形の精神病発現、変性
関接症神経病痛覚、不眠症などに対する治療効果
のあることが見い出されており、その大量生産が
期待されている。
従来、SAMの製造方法としては種々の微生物
を用いる培養法が知られているが、なかでも酵母
を用いる方法が好ましいとされており、その具体
例としてサツカロマイセス属またはキヤンデイダ
属の微生物を用いる方法(例えばJournal of
Bacteriology、vol121、267頁(1975年)など)、
ピヒア属、ロドトルラ属、クリプトコツカス属、
ハンゼヌラ属、トリコスポロン属、クレケラ属、
ハンゼニアスポラ属、スポロボロミセス属、リポ
ミセス属またはデバリオミセス属の微生物を用い
る方法(特公昭52−17118号)などが知られてい
る。しかしながら、これらの方法においても
SAMの蓄積量は必ずしも充分満足できるものと
はいえず、より一層の改良が求められていた。
そこで本発明者らは醗酵法によるSAMの蓄積
向上につき鋭意検討を加えた結果、SAMの前駆
体であるメチオニンとともに特定な化合物を添加
した培地を用いることが有効であることを見い出
し、本発明を完成した。
すなわち本発明の目的は生産能に優れた発酵法
によるSAMの製造方法を提供することにあり、
かかる本発明の目的は、SAM生産能を有する酵
母をメチオニン含有培地で培養してSAMを製造
する方法において、培地中に(A)ウラシル、チミン
及びプリンからなる群から選択された少なくとも
一種の塩基類、(B)イノシン、グアノシン、キサン
トシン、ウリジン、シチジン、チミジン、デオキ
シアデノシンからなる群から選択された少なくと
も一種のヌクレオシド類、(C)イノシン−5′−モノ
リン酸、グアノシン−5′−モノリン酸、キサント
シン−5′−モノリン酸、ウリジン−5′−モノリン
酸、シチジン−5′−モノリン酸、アデノシン−
2′−モノリン酸、アデノシン−3′−モノリン酸、
デオキシアデノシン−5′−モノリン酸及びデオキ
シチミジン−5′−モノリン酸からなる群から選択
された少なくとも一種のヌクレオチド類、(D)リボ
核酸または(E)デオキシリボ核酸を0.01g/dl以
上、好ましくは0.02g/dl以上の濃度で存在せし
めることにより達成される。
本発明において用いられる酵母はメチオニン含
有培地中でSAMを蓄積する能力を有するもので
あればいずれでもよく、サツカロマイセス
(Saccharomyces)属、キヤンデイダ(Candida)
属、ハンゼヌラ(Hansenula)属、ピヒア
(Pichia)属、ロドトルラ(Rhodotorula)属、
クリプトコツカス(Cryptococcus)属、トリコ
スポロン(Trichosporon)属、クレケラ
(Kloeckera)属、ハンゼニアスポラ
(Hanseniaspora)属、スポロボロミセス
(Sporobolomyces)属、リポミセス
(Lipomyces)属、デバリオミセス
(Debaryomyces)属などに属する酵母が挙げら
れ、その具体例としてサツカロマイセス・セレビ
ジエIFO2346、キヤンデイダ・マセドニエンシス
IFO0960、ハンゼヌラ・フアビアニイIFO1370、
ピヒア・フアリノサIFO0193、ロドトルラ・グル
チニスIFO0389、クリプトコツカス・アルビダス
IFO0385、トリコスポロン・カピタタム
IFO0743、クレケラ・アピキユラタIFO0151、ハ
ンゼニアスポラ・バルバイエンシスIFO0115、ス
ポロボロミセス・サルモニカラーIFO0374、リポ
ミセス・リポフエルIFO0673、デバリオミセス・
ハンゼニイIFO0026などが挙げられる。またこれ
らの天然及び人工変異菌であつてもSAM生産能
を有するかぎり同様に使用することができる。
本発明においては前記のごとき特定な化合物を
単独または2種以上の併用の形で存在せしめるこ
と以外、常法に従つて培地が調整される。例えば
炭素源としてグルコース、シユクロース、フラク
トース等の糖類、酢酸などの有機酸類、炭化水素
類、メタノール、エタノールなどのアルコール類
などを用いることができ、更に通常の窒素源、無
機塩、有機微量栄養素が必要に応じて使用され
る。
培養は好気的条件が良く、培養温度は20℃から
40℃の範囲が好ましい。培養の際、培地のPHを3
から8の範囲に調節すれば通常最も望ましい結果
が得られる。かくして培養2日から10日後には菌
体中および/又は培養液中にSAMが生成蓄積す
るので、これを常法に従つて処理することにより
SAMを取得することができる。
例えばSAM含有菌体を過塩素酸で抽出し、抽
出液を氷冷下に炭酸水素カリウムで中和したの
ち、必要に応じて強酸性カチオン交換樹脂に接触
させ、次いでSAMを吸着したのち硫酸で溶出し、
溶出液にリンタングステス酸を加えてSAMを沈
澱させることによつて単離することができる。
以下に実施例を挙げて本発明をさらに具体的に
説明するが、本発明はこれに限定されるものでは
ない。なお、実施例におけるSAMの定量は次の
ようにして行つた。すなわち、培養終了後、遠心
分離にて菌体と培養液を分離し、菌体を約5倍量
の1.5N過塩素酸で抽出した。次いで得られた抽
出上澄液を培養液と混合したのち、ペーパークロ
マトグラフイー(展開溶媒:エタノール/1−ブ
タノール/水/酢酸/1%ピロリン酸ナトリウム
水溶液=35/30/30/1/1)で分離し、紫外線
検出器でSAM相当のスポツトを検出し、これを
0.1N塩酸で抽出して、その260nmの吸光度より
試料中のSAM量を検出した。
実施例 1
グルコース5g/dl、ポリペプトン0.5g/dl、
KH2PO40.4g/dl、K2HPO40.4g/dl、
MgSO4・7H2O0.02g/dl、酵母エキス0.2g/
dl、寒天2g/dlからなる寒天斜面培地(PH6.0)
に2日間生育させたサツカロマイセス・セレビジ
エIFO2346の1白金耳を、サツカロース10g/dl
カザミノ酸1g/dl、トリプトン(Bacto
tryptone)1g/dl、KH2PO4、0.4g/dl、
K2HPO41g/dl、MgSO4・7H2O0.04g/dl、L
−メチオニン0.75g/dl及び所定量のプリンから
なりPH6.0に調整、加熱滅菌した培地5mlに植菌
し、28℃で5日間振盪した。次いでSAMの蓄積
量を測定し、結果を第1表に示した。
The present invention relates to a method for producing S-adenosylmethionine (hereinafter abbreviated as SAM) by a fermentation method,
More specifically, the present invention relates to a method for efficiently producing SAM by culturing yeast in a methionine-containing liquid medium supplemented with a specific compound. SAM is an important substance involved in the metabolism of fats, proteins, sugars, etc. in vivo. Recently, it has been discovered that SAM has a therapeutic effect on hepatemia, hyperlipidemia, arteriosclerosis, depression and neurological manifestations of psychosis, degenerative joint disease, neurological pain sensation, insomnia, etc. mass production is expected. Conventionally, cultivation methods using various microorganisms have been known as methods for producing SAM, but among these methods, methods using yeast are considered preferable, and a specific example is a method using microorganisms of the genus Satucharomyces or Candeida ( For example, Journal of
Bacteriology, vol 121, p. 267 (1975), etc.)
Pichia spp., Rhodotorula spp., Cryptococcus spp.
Hansenula spp., Trichosporon spp., Crecera spp.
Methods using microorganisms of the genus Hanseniaspora, Sporobolomyces, Lipomyces, or Debaryomyces (Japanese Patent Publication No. 17118/1982) are known. However, even in these methods
The accumulated amount of SAM was not necessarily fully satisfactory, and further improvements were required. Therefore, the present inventors conducted intensive studies on improving the accumulation of SAM by fermentation, and found that it is effective to use a medium to which methionine, a precursor of SAM, and a specific compound were added. completed. That is, the purpose of the present invention is to provide a method for producing SAM using a fermentation method with excellent productivity.
The object of the present invention is to provide a method for producing SAM by culturing yeast capable of producing SAM in a methionine-containing medium, in which the medium contains (A) at least one base selected from the group consisting of uracil, thymine, and purine; (B) at least one nucleoside selected from the group consisting of inosine, guanosine, xanthosine, uridine, cytidine, thymidine, and deoxyadenosine, (C) inosine-5'-monophosphate, guanosine-5'-monophosphate , xanthosine-5'-monophosphate, uridine-5'-monophosphate, cytidine-5'-monophosphate, adenosine-
2'-monophosphoric acid, adenosine-3'-monophosphoric acid,
At least one nucleotide selected from the group consisting of deoxyadenosine-5'-monophosphate and deoxythymidine-5'-monophosphate, (D) ribonucleic acid or (E) deoxyribonucleic acid, preferably at least 0.01 g/dl. This is achieved by making it exist at a concentration of 0.02 g/dl or more. The yeast used in the present invention may be any yeast as long as it has the ability to accumulate SAM in a methionine-containing medium.
Genus, Hansenula, Pichia, Rhodotorula,
Belongs to the genus Cryptococcus, Trichosporon, Kloeckera, Hanseniaspora, Sporobolomyces, Lipomyces, Debaryomyces, etc. Yeasts include Satucharomyces cerevisiae IFO2346 and Candeida macedoniensis as specific examples.
IFO0960, Hanzenula Huabianii IFO1370,
Pihia falinosa IFO0193, Rhodotorula glutinis IFO0389, Cryptococcus albidus
IFO0385, Trichosporon capitatum
IFO0743, Crechera apiquyulata IFO0151, Hanseniaspora barbaiensis IFO0115, Sporobolomyces salmonicolor IFO0374, Lipomyces lipofuel IFO0673, Debaryomyces
Examples include Hanzenii IFO0026. Furthermore, these natural and artificial mutant bacteria can be similarly used as long as they have the ability to produce SAM. In the present invention, the culture medium is prepared according to a conventional method except that the specific compounds mentioned above are present alone or in combination of two or more kinds. For example, sugars such as glucose, sucrose, and fructose, organic acids such as acetic acid, hydrocarbons, alcohols such as methanol and ethanol, etc. can be used as carbon sources, and in addition, ordinary nitrogen sources, inorganic salts, and organic micronutrients can be used. Used as needed. Cultivation is performed under good aerobic conditions, and the culture temperature is from 20℃.
A range of 40°C is preferred. During culture, adjust the pH of the medium to 3.
Adjusting to a range of 8 to 8 usually yields the most desirable results. Thus, after 2 to 10 days of culture, SAM is produced and accumulated in the bacterial cells and/or the culture solution, and this can be treated using conventional methods.
Able to obtain SAM. For example, SAM-containing bacterial cells are extracted with perchloric acid, the extract is neutralized with potassium bicarbonate under ice-cooling, and if necessary, it is brought into contact with a strongly acidic cation exchange resin, then SAM is adsorbed, and then sulfuric acid is added. Elute,
SAM can be isolated by adding phosphotungstic acid to the eluate to precipitate it. The present invention will be described in more detail with reference to Examples below, but the present invention is not limited thereto. In addition, the quantification of SAM in Examples was performed as follows. That is, after the cultivation was completed, the bacterial cells and the culture solution were separated by centrifugation, and the bacterial cells were extracted with about 5 times the amount of 1.5N perchloric acid. Next, the obtained extraction supernatant was mixed with the culture solution, and then subjected to paper chromatography (developing solvent: ethanol/1-butanol/water/acetic acid/1% aqueous sodium pyrophosphate solution = 35/30/30/1/1 ), a UV detector detects spots equivalent to SAM, and
The sample was extracted with 0.1N hydrochloric acid, and the amount of SAM in the sample was detected from its absorbance at 260 nm. Example 1 Glucose 5g/dl, polypeptone 0.5g/dl,
KH 2 PO 4 0.4g/dl, K 2 HPO 4 0.4g/dl,
MgSO 4・7H 2 O0.02g/dl, yeast extract 0.2g/
dl, agar slant medium consisting of agar 2g/dl (PH6.0)
One platinum loop of Satucharomyces cerevisiae IFO2346 grown for 2 days was added to Satucharose 10g/dl.
Casamino acids 1g/dl, tryptone (Bacto
tryptone) 1g/dl, KH 2 PO 4 , 0.4g/dl,
K 2 HPO 4 1g/dl, MgSO 4・7H 2 O0.04g/dl, L
- 5 ml of a heat-sterilized medium containing 0.75 g/dl of methionine and a predetermined amount of purine, adjusted to pH 6.0, was inoculated and shaken at 28°C for 5 days. Next, the amount of accumulated SAM was measured, and the results are shown in Table 1.
【表】
実施例 2
プリンのかわりに第2表に示す化合物を0.05
g/dlの濃度で培地に添加すること以外は実施例
1と同じ条件で培養を実施した。結果を第2表に
示した。[Table] Example 2 Add 0.05 of the compound shown in Table 2 instead of purine.
Cultivation was carried out under the same conditions as in Example 1, except that it was added to the medium at a concentration of g/dl. The results are shown in Table 2.
【表】
実施例 3
サツカロマイセス・セレビジエIFO2346の代り
に第3表に示す菌株を用い、かつ0.05g/dlの各
種化合物を培地に添加すること以外は実施例1と
同じ条件で培養を行つた。結果を第3表に示し
た。[Table] Example 3 Culture was carried out under the same conditions as in Example 1, except that the strains shown in Table 3 were used instead of S. cerevisiae IFO2346, and 0.05 g/dl of various compounds were added to the medium. The results are shown in Table 3.
【表】【table】
【表】
実施例 4
実施例1と同様な寒天斜面培地に2日間生育さ
せたサツカロマイセス・セレビジエIFO2346の1
白金耳をシユクロース10g/dl、酵母エキス1
g/dl、KH2PO40.4g/dl、MgSO4・7H2O0.01
g/dl、Urea(別滅菌)1.8g/dl、L−メチオ
ニン0.75g/dl、CaCl2・2H2O0.02g/dl、
ZnSO4・7H2O0.25mg/dl、FeSO4・7H2O0.25
mg/dl、プリン0.05g/dl及びキサントシン−
5′−モノリン酸0.05g/dlからなりPH6.0に調整、
加熱滅菌した培地5mlに植菌した。28℃で5日間
振盪した後、SAMの蓄積量を測定すると0.36
g/dlであつた。また、プリン及びキサントシン
−5′−モノリン酸を添加しないで同様な培養を実
施したところ、SAM蓄積量は0.19g/dlであつ
た。
実施例 5
サツカロマイセス・セレビジエIFO2346の代わ
りに第5表に示す菌株を用い、かつ0.05g/dlの
プリンを培地に添加すること以外は実施例1と同
じ条件で培養を行つた。結果を第5表に示した。[Table] Example 4 1 of Satucharomyces cerevisiae IFO2346 grown for 2 days on the same agar slant medium as in Example 1
Platinum looper with 10 g/dl of sucrose, 1 yeast extract
g/dl, KH 2 PO 4 0.4g/dl, MgSO 4・7H 2 O0.01
g/dl, Urea (sterilized separately) 1.8g/dl, L-methionine 0.75g/dl, CaCl 2 2H 2 O 0.02g/dl,
ZnSO 4・7H 2 O0.25mg/dl, FeSO 4・7H 2 O0.25
mg/dl, purine 0.05g/dl and xanthosin-
Contains 0.05g/dl of 5′-monophosphoric acid, adjusted to pH 6.0,
The cells were inoculated into 5 ml of heat-sterilized medium. After shaking at 28℃ for 5 days, the amount of SAM accumulated was 0.36.
g/dl. Furthermore, when similar culture was carried out without adding purine and xanthosine-5'-monophosphate, the amount of SAM accumulated was 0.19 g/dl. Example 5 Culture was carried out under the same conditions as in Example 1, except that the strains shown in Table 5 were used instead of Saccharomyces cerevisiae IFO2346, and 0.05 g/dl of purine was added to the medium. The results are shown in Table 5.
Claims (1)
母をメチオニン含有培地で培養してS−アデノシ
ルメチオニンを製造する方法において、培地中に
(A)ウラシル、チミン及びプリンからなる群から選
択された少なくとも一種の塩基類、(B)イノシン、
グアノシン、キサントシン、ウリジン、シチジ
ン、チミジン及びデオキシアデノシンからなる群
から選択された少なくとも一種のヌクレオシド
類、(C)イノシン−5′−モノリン酸、グアノシン−
5′−モノリン酸、キサントシン−5′−モノリン
酸、ウリジン−5′−モノリン酸、シチジン−5′−
モノリン酸、アデノシン−2′−モノリン酸、アデ
ノシン−3′−モノリン酸、デオキシアデノシン−
5′−モノリン酸及びデオキシチミジン−5′−モノ
リン酸からなる群から選択された少なくとも一種
のヌクレオチド類、(D)リボ核酸又は(E)デオキシリ
ボ核酸を0.01g/dl以上の濃度で存在せしめるこ
とを特徴とするS−アデノシルメチオニンの製造
方法。 2 酵母がサツカロマイセス属、キヤンデイダ属
またはハンゼヌラ属に属するものである特許請求
の範囲第1項記載の方法。[Claims] 1. A method for producing S-adenosylmethionine by culturing yeast capable of producing S-adenosylmethionine in a methionine-containing medium, which comprises
(A) at least one base selected from the group consisting of uracil, thymine, and purine; (B) inosine;
At least one nucleoside selected from the group consisting of guanosine, xanthosine, uridine, cytidine, thymidine and deoxyadenosine, (C) inosine-5'-monophosphate, guanosine-
5'-monophosphoric acid, xanthosine-5'-monophosphoric acid, uridine-5'-monophosphoric acid, cytidine-5'-
Monophosphoric acid, adenosine-2'-monophosphoric acid, adenosine-3'-monophosphoric acid, deoxyadenosine-
Presence of at least one nucleotide selected from the group consisting of 5'-monophosphoric acid and deoxythymidine-5'-monophosphoric acid, (D) ribonucleic acid, or (E) deoxyribonucleic acid at a concentration of 0.01 g/dl or more. A method for producing S-adenosylmethionine, characterized by: 2. The method according to claim 1, wherein the yeast belongs to the genus Satucharomyces, Candeida, or Hansenula.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56138879A JPS5840096A (en) | 1981-09-03 | 1981-09-03 | Production of s-adenosylmethionine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56138879A JPS5840096A (en) | 1981-09-03 | 1981-09-03 | Production of s-adenosylmethionine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5840096A JPS5840096A (en) | 1983-03-08 |
| JPH0153038B2 true JPH0153038B2 (en) | 1989-11-10 |
Family
ID=15232241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56138879A Granted JPS5840096A (en) | 1981-09-03 | 1981-09-03 | Production of s-adenosylmethionine |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5840096A (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6078594A (en) * | 1983-10-05 | 1985-05-04 | Yamasa Shoyu Co Ltd | Preparation of s-adenosyl-l-methionine |
| EP1038951A1 (en) * | 1999-03-23 | 2000-09-27 | Societe Des Produits Nestle S.A. | Synthetic medium for cultivating lactobacillus and/or bifidobacteria |
| JP5989319B2 (en) * | 2011-10-06 | 2016-09-07 | ライオン株式会社 | Sleep quality improver |
| WO2019160059A1 (en) * | 2018-02-14 | 2019-08-22 | 国立大学法人大阪大学 | Method for recycling s-adenosylmethionine |
-
1981
- 1981-09-03 JP JP56138879A patent/JPS5840096A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5840096A (en) | 1983-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Green et al. | Interactions of vinyl chloride with rat-liver DNA in vivo | |
| Holmgren et al. | Enzymatic synthesis of deoxyribonucleotides, 8. The effects of ATP and dATP in the CDP reductase system from E. coli. | |
| US6387667B1 (en) | Process for producing cytidine diphosphate choline | |
| HK1000604B (en) | Process for producing cytidine diphosphate choline | |
| KR101311571B1 (en) | Method for purification of cytidinediphosphoric choline | |
| US4562149A (en) | Yeast culture containing S-adenosyl methionine in high concentrations, and process for production of S-adenosyl methionine | |
| US3535207A (en) | Method of converting heterocyclic bases into the corresponding nucleosides by bacterial action | |
| JPH0153038B2 (en) | ||
| DE69027154T2 (en) | Process for the preparation of nucleosides by using phosphorylases obtainable from Bacillus stearothermophilus | |
| JP3651036B2 (en) | Method for producing nucleoside-5'-phosphate ester | |
| JPH0153037B2 (en) | ||
| Ishiyama et al. | Cyclic-AMP Production by Corynebacterium murisepticum No. 7 (ATCC 21374) and Microbacterium sp. No. 205 (ATCC 21376) | |
| Isono et al. | Purification and reaction of a new enzyme, nucleoside oxidase | |
| US5008188A (en) | Process for producing S-adenosyl-L-homocysteine | |
| MITSUDA et al. | Fluctuation of the nucleotide pools of flavinogenic and nonflavinogenic strains of Eremothecium ashbyii grown in the presence of purines | |
| US4371613A (en) | Method for producing purine arabinosides | |
| US3879260A (en) | Process for production of ribosides of nucleic acid base derivatives and analogues thereof | |
| JPH0378117B2 (en) | ||
| IMADA et al. | DEGRADATION OF PYRIMIDINE NUCLEOTIDES BY ENZYME SYSTEMS OF STREPTOMYCES I. RIBOSE-5-PHOSPHATE FORMATION FROM PYRIMIDINE NUCLEOTIDES | |
| Fujimoto et al. | Conversion of Hypoxanthine to Xanthosine by a Guanineless Mutant of Bacillus subtilis | |
| Tanaka et al. | Production of Nucleic Acid-related Substances by Fermentative Processes: Part XXXIX. Production of Ribotides of 6-Azauracil and Some Pyrimidines by Brevibacterium ammoniagenes | |
| JPH1028593A (en) | Production of hypoxanthine | |
| Rosenberg et al. | Conversion of D-mannitol to D-ribose: a newly discovered pathway in Escherichia coli | |
| JP4021945B2 (en) | A method for recovering oxidized β-nicotinamide adenine dinucleotide in yeast. | |
| Lynn | Nucleic Acid Metabolism of Pleuropneumonialike Organisms |